RHUDEX
Medigene AG
Mark For: RHUDEX® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88245830 |
| Registration Number | 5812401 |
| Mark Literal Elements | RHUDEX |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-07-23 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | David A. Bell |
| Attorney Docket Number | 52318.3 |
Timeline
| 2018-12-31 | Application Filed |
| 2019-01-03 | Location: NEW APPLICATION PROCESSING |
| 2019-01-03 | Status: Live/Pending |
| 2019-01-04 | Transaction Date |
| 2019-05-07 | Published |
| 2019-05-07 | Published for Opposition |
| 2019-07-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-07-23 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2019-07-23 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Medigene AG |
| Address | Lochhamer Str. 11 Planegg-Martinsried GERMANY 82152 |
| Legal Entity Type | Aktiengesellschaft |
| Legal Entity State | GERMANY |
Documents
 Drawing | JPEG | 2018-12-31 |
 TEAS RF New Application | MULTI | 2018-12-31 |
| Preliminary Amendment | MULTI | 2019-03-08 |
| XSearch Search Summary | XML | 2019-03-20 |
| Amendment and Mail Process Complete | MULTI | 2019-03-21 |
| Examiners Amendment | XML | 2019-03-22 |
| Notation to File | XML | 2019-03-22 |
| Amendment and Mail Process Complete | MULTI | 2019-03-26 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-03-26 |
| Notice of Publication | XML | 2019-04-17 |
| Notification Of Notice of Publication | XML | 2019-04-17 |
| OG Publication Confirmation | XML | 2019-05-07 |
| Registration Certificate | 2019-07-23 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
IC 010. US 026 039 044. G & S: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes
IC 042. US 100 101. G & S: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology |
| GS0051 | Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2019-07-23 | |
| PUBLISHED FOR OPPOSITION | 2019-05-07 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-05-07 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-04-17 | |
| EXAMINER'S AMENDMENT ENTERED | 2019-03-25 | 68552 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-03-25 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-03-22 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2019-03-22 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2019-03-22 | 81856 |
| ASSIGNED TO EXAMINER | 2019-03-20 | 81856 |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2019-03-20 | 73296 |
| ASSIGNED TO LIE | 2019-03-11 | 73296 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2019-03-08 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-01-22 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-01-03 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RHUDEX 88245830 not registered Live/Pending |
Medigene AG 2018-12-31 |
 RHUDEX 85362627 4322812 Dead/Cancelled |
Medigene Limited 2011-07-04 |
 RHUDEX 78285532 2943640 Dead/Cancelled |
MEDIGENE LIMITED 2003-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 